Use LEFT and RIGHT arrow keys to navigate between flashcards;
Use UP and DOWN arrow keys to flip the card;
H to show hint;
A reads text to speech;
73 Cards in this Set
- Front
- Back
How is neuroblastoma defined?
|
A malignancy of the sympathetic nervous system
|
|
Where does neuroblastoma develop from?
|
Neural crest cells
|
|
How is neuroblastoma usually identified upon assessment?
|
A mass is found in the neck, chest, and/or abdomen, most arising from the adrenal gland
|
|
What constitutes a neuroblastoma?
|
Solid soft mass w/microscopic nests of small tumor cells separated by fibrovascular septa w/areas of hemorrhage, calcification, & necrosis
|
|
What is a neuroblastoma cell composed of?
|
Small round cells w/blue granules w/varied maturation
|
|
What are the malignant forms of neuroblastoma?
|
1. Neuroblastoma
2. Ganglioneuroblastoma |
|
What type of neuroblastoma is the most mature/benign form w/out metastatic potential?
|
Ganglioneuroma
|
|
How does one differentiate neuroblastoma from other small, round, blue-cell tumors pathology?
|
Using electron microscopy & immunohistochemistry Pseudorosettes can be seen in 15-50% of cases
|
|
What are key factors in developing an appropriate treatment plan for a neuroblastoma diagnosis?
|
Biology of each tumor
Age of child at diagnosis |
|
What is N-myc amplification associated with for neuroblastoma patients?
|
Advanced stages
Rapid tumor progression Poor prognosis |
|
N-myc amplification refers to what?
|
Less than 10 copies of the N-myc oncogene
|
|
What is High-TrkA expression associated with?
|
1. Favorable group biologically & clinically
2. Infants up to 1yr old 3. Stages 1,2, & 4S |
|
What also may High-TrkA gene expression be associated with?
|
Cell differentiation
Tumor regression |
|
Then what does lack of TrkA expression and a high expression of the TrkB gene associated with?
|
Unfavorable NB (stage 4)
|
|
What chromosome deletions & gains have been linked to a loss of heterozygosity and of "neuroblastoma suppressor genes"?
|
Deletion 1p and 11q
Gain of 17q |
|
What has a more favorable prognosis hyperdiploidy or diploidy in Neuroblastoma tumor cytogenetics?
|
Diploid (DNA index of 1) = more likely to have advanced disease & less favorable outcomes
*(Hyperdiploid = DNA index >1) |
|
T or F: Accounting for approx. 8% of all childhood cancers, Neuroblastoma is the most common extracranial solid tumor in children.
|
True
|
|
What age group is it considered the most common malignancy?
|
Infants = accounts for 50% of all malignancies in newborns
|
|
What phenomenon occurs that make it difficult to assess incidence accurately?
|
Spontaneous tumor regression and maturation
|
|
What is the average age of diagnosis for Neuroblastomas?
|
2 years old; 90% are diagnosed by age 5yrs;
Rare after 10yrs of age |
|
What is the neuroblastoma tumors nickname and why?
|
"the silent tumor" - b/c presents w/widespread metastatic disease at diagnosis in 60% of patients
|
|
What other conditions/diseases are known to have an increased incidence of NB?
|
1. Neurofibromatosis Type 1
2. Hirschsprung disease 3. Central hypoventilation (Ondine's curse) |
|
What percentage of NB patients report a family history?
|
1 to 2% - typically occurs sporadically
|
|
T or F: The small population that reports familial history of NB have transmission through an autosomal recessive gene
|
False: Autosomal Dominant Gene
*Incr'd incidence among siblings & identical twins |
|
Are screening studies beneficial in reducing the incidence of late-appearing advanced-stage disease?
|
No - 6mo or younger - screening studies were found to NOT reduce incidence
|
|
Are signs & symptoms of NB always specific to tumor location and metastatic sites?
|
No, they can be generalized - as tumors can occur anywhere along sympathetic nervous system.
|
|
In more than 50% of NB cases, the primary site of disease arises from what gland?
|
Adrenal Gland
(30% occur in the abdomen) (15% are thoracic in origin) |
|
What location of a tumor is generally associated with localized disease?
|
Thoracic primary tumor (Stages 1-3)
|
|
An adrenal primary tumor is associated with what stage of disease?
|
Stages 4 and 4S
|
|
What sites are considered metastatic?
|
- Lymph nodes
- Bone - Bone Marrow - Liver - Subcutaneous tissue |
|
What are other sites NB can be located?
|
Head
Posterior Mediastinum Pelvis Neck |
|
In the rare occasion NB spreads to the lung and/or brain, what should be considered?
|
Relapsing or End-stage disease
|
|
What should one consider if a patient develops malaise, low-grade fever, or limp?
|
Bone or bone marrow metastases
|
|
What is a common cause of hypertension in a patient w/NB?
|
Pressure from tumor on the renal artery, therefore activating the renin-angiotensin system
|
|
What is being described when someone uses the term a "blueberry muffin" sign?
|
A subcutaneous tumor = hardened bluish nodule seen or palpated
|
|
What type of tumor is often mistaken for child abuse?
|
Periorbital tumor that has caused proptosis and/or periorbital ecchymoses
|
|
What location of tumor tends to form a dumbbell-shaped mass and causes cord compression?
|
Intervertebral ganglion tumor that has grown into the intervertebral foramena
|
|
If a patient develops paralysis, weakness in extremities, incontinence, and pain, what is happening?
|
Cord Compression = Oncologic emergency
|
|
What is Horner syndrome?
|
Unilateral ptosis
Myosis anhydrosis |
|
What location is a tumor if a patient develops Horner syndrome?
|
High thoracic and cervical masses
2.4% of diagnoses patients |
|
What unique paraneoplastic syndromes present at an early age & have been associated predominantly w/localized NB?
|
Opsomyoclonus = myoclonic jerking and random eye movement
Cerebellar ataxia 1.3% of NB patients |
|
What casues 5% of patients to have intractable diarrhea, resulting in hypoK+ & dehydration?
|
Secretion of VIP (vasoactive intestinal polypeptide) by tumor
|
|
Tumors that secrete VIP are mostly type?
|
Mature histologically (Ganglioneuroblastoma or ganglioneuroma) = favorable outcomes
|
|
At time of diagnoses, what urine test should be done prior to start of therapy?
|
Urine catechloamines - increased in 90-95% of cases
|
|
What percentage of NB patients have disease identified on BM biopsy?
|
11-30% biopsies Positive when aspirates were negative
|
|
Must biopsy the tumor to confirm diagnosis & what?
|
Determine N-myc & ploidy status
|
|
What scan is extremely useful in determining metastatic NB disease?
|
MIBG (Metaiodobenzylguanidine)
|
|
Then what is a PET/CT for?
|
assessing metastatic disease not sensitive to MIBG
|
|
What cooperative group has developed a universal staging system?
|
International Neuroblastoma Staging System (INSS)
|
|
Read page 34 for NB stages Table 2-9
|
Stages 1, 2A, 2B, 3, 4, 4S
|
|
What factors must one consider when evaluating prognosis for a NB patient?
|
1. INSS stage
2. age at diagnosis 3. N-myc status 4. tumor histology/DNA ploidy |
|
What stages are considered low risk NB?
|
Stages 1 & 2
Stage 4S (younger than 1yr of age) Greater than 90% EFS |
|
What stages are Intermediate Risk?
|
Stage 3
Stage 4 (younger than 1year of age) Stage 4S w/large liver mets or diploid DNA index |
|
What stages are High Risk?
|
Stage 4 (older than 1yr of age)
N-myc amplification regardless of age or stage Overall 5-yr survival = 30-40% |
|
What are the 7 treatments offered to varying degrees of NB diagnoses?
|
1. Observation alone
2. Surgery 3. Chemo 4. Raidiation Therapy 5. BM w/HD chemo & SCR 6. Immunotherapy 7. Retinoid compounds |
|
What is treatment based on for patients w/NB?
|
Staging & risk factors at time of diagnosis
|
|
What 4 phases of treatment do high-risk NB patients receive?
|
1 - Induction chemo
2 - primary site, local control (surgery & radiation) 3 - high-dose marrow ablative therapy 4 - manage min residual disease |
|
When is observation alone considered as a treatment option?
|
Pt's <1year with stage 4S disease & favorable biology
- poss spontaneous regression |
|
When is surgery alone a curative treatment?
|
Low-stage disease (stage 1&2)
- offers 5yr EFS >90% |
|
What is the common chemo regimen when treating intermediate-risk NB?
|
Low dose chemo for 4-8 cycles
|
|
What is the common chemo regimen when treating high-risk NB?
|
High-dose induction chemo
includes - Cytoxan, Adraimycin, VCR, Cisplatin & VP16 |
|
When can radiation therapy be used as treatment in NB?
|
Administered to:
- primary site after surgical resection - metastatic sites that don't resolve w/chemo alone |
|
What treatment is used in emergency situations such as proptosis or cord compression?
|
Radiation before surgery to decrease surgical risks
|
|
What chemo is typically used in a high-risk patients receiving a bone marrow transplant?
|
Carboplatin
Etoposide Melphalan Cyclophosphamide Thiotepa |
|
Is TBI always used as part of the treatment with HD chemo and BMT w/SCR?
|
No
If it is used w/a tandem BMT, it is administered w/second treatment |
|
When is immunotherapy especially considered as part of NB treatment?
|
Minimal residual disease
|
|
How does immunotherapy work in treating NB?
|
monoclonal antibdy produced from WBC of mice, attaches to NB specific cell surface ganglioside GD2 & used w/cytokines
|
|
What normal process does the monoclonal antibody signal to help treat NB?
|
Own immune system attacks & kills the NB cell
|
|
When is isotretinoin used in the treatment of NB?
|
Standard of care for high-risk pt's w/MRD.
|
|
How does isotretinoin (retinoid compound) treat MRD?
|
Induces apoptosis & differentiation
|
|
In low- or intermediate-risk disease w/local relapse what treatment option may be curative?
|
Second surgery
(or w/ or w/out chemo &/or radiation) |
|
Pt. w/high-risk relapse or recurrent disease what are some current approaches to treatment?
|
1. Cytotoxic agents - Cytoxan, topotecan & irinotecan
2. Radionuclides - w/MIBG, somatostatin analogs radiation is delievered directly to NB cells 3. Retinoid compounds - fenretinide induces cytotoxicity in NB cells |
|
What are the 4 goals of nursing assessment & intervention with a NB diagnosis?
|
Pt. will experience minimal complications related to 1) onset of tumor; 2) treatment.
Pt. & family will 3)be adequately informed re:dx, disease & treatment; 4) cope adequately w/ the diagnosis. |